BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 24857919)

  • 1. Cancer stem cell theory and the warburg effect, two sides of the same coin?
    Pacini N; Borziani F
    Int J Mol Sci; 2014 May; 15(5):8893-930. PubMed ID: 24857919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic alterations in cancer cells and therapeutic implications.
    Hammoudi N; Ahmed KB; Garcia-Prieto C; Huang P
    Chin J Cancer; 2011 Aug; 30(8):508-25. PubMed ID: 21801600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects of the Warburg effect in cancer cell biology.
    Bensinger SJ; Christofk HR
    Semin Cell Dev Biol; 2012 Jun; 23(4):352-61. PubMed ID: 22406683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells.
    Menendez JA; Joven J; Cufí S; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; López-Bonet E; Alarcón T; Vazquez-Martin A
    Cell Cycle; 2013 Apr; 12(8):1166-79. PubMed ID: 23549172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem metabolism: Insights from oncometabolism and vice versa.
    Rodrigues AS; Pereira SL; Ramalho-Santos J
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165760. PubMed ID: 32151634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
    Icard P; Shulman S; Farhat D; Steyaert JM; Alifano M; Lincet H
    Drug Resist Updat; 2018 May; 38():1-11. PubMed ID: 29857814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated multidisciplinary model describing initiation of cancer and the Warburg hypothesis.
    Rietman EA; Friesen DE; Hahnfeldt P; Gatenby R; Hlatky L; Tuszynski JA
    Theor Biol Med Model; 2013 Jun; 10():39. PubMed ID: 23758735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis.
    Savage P
    BMC Cancer; 2016 Nov; 16(1):906. PubMed ID: 27871274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells.
    Li L; Bi Z; Wadgaonkar P; Lu Y; Zhang Q; Fu Y; Thakur C; Wang L; Chen F
    Semin Cancer Biol; 2019 Aug; 57():10-18. PubMed ID: 31009762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer metabolism in space and time: Beyond the Warburg effect.
    Danhier P; Bański P; Payen VL; Grasso D; Ippolito L; Sonveaux P; Porporato PE
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):556-572. PubMed ID: 28167100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept.
    Yuen CA; Asuthkar S; Guda MR; Tsung AJ; Velpula KK
    CNS Oncol; 2016; 5(2):101-8. PubMed ID: 26997129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unveiling of the Warburg effect and the inscribed innovative approach to a radical non toxic anticancer therapy.
    Crociani O; Marzi I; Cipolleschi MG; Mannini A; Contini M; Olivotto M
    Cell Cycle; 2018; 17(3):288-297. PubMed ID: 29160745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro.
    Zhong Y; Li X; Yu D; Li X; Li Y; Long Y; Yuan Y; Ji Z; Zhang M; Wen JG; Nesland JM; Suo Z
    Oncotarget; 2015 Nov; 6(35):37758-69. PubMed ID: 26413751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cell metabolism.
    Peiris-Pagès M; Martinez-Outschoorn UE; Pestell RG; Sotgia F; Lisanti MP
    Breast Cancer Res; 2016 May; 18(1):55. PubMed ID: 27220421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.